期刊文献+

人乳头瘤病毒HPV E6/E7 mRNA检测在宫颈病变诊断中的价值 被引量:3

Value of human papillomavirus E6/E7 mRNA detection in diagnosis of cervical lesions
下载PDF
导出
摘要 目的:评估HPV E6/E7 mRNA在宫颈病变诊断中的价值。方法:选取弋矶山医院2014年9月~2015年9月HPV DNA阳性且TCT检测为慢性宫颈炎患者197例,行HPV E6/E7 mRNA及阴道镜下宫颈组织病理学检测。结果:197例HPV阳性患者中,HPV E6/E7 mRNA的阳性率为62.44%,敏感度为91.18%,特异度为52.17%,阳性预测值为50.14%,阴性预测值为91.89%。不同组织学分级中,HPV E6/E7 mRNA的阳性表达率在宫颈炎组与CINⅠ组、宫颈炎组与Ⅱ组、宫颈炎组与Ⅲ组均具有统计学差异(P〈0.01)。HPV E6/E7 mRNA检测与病理学诊断符合率为90%。结论:HPV E6/E7mRNA的表达与宫颈病变密切相关,可用于评估宫颈癌的发病风险。在早期或低级别病变中,HPV E6/E7 mRNA检测对预测高级别宫颈上皮内瘤变的发生有着重要作用。 Objective: To assess the value of human papilloma virus( HPV) E6 /E7 mRNA detection in the diagnosis of cervical lesions. Methods: A total of 197 HPV positive cases confirmed as chronic cervicitis by Thin-prep liquid-based Cytology Test( TCT) were included from Yijishan Hospital of Wannan Medical College between September of 2014 and 2015,and all patients were given further detection of HPV E6 / E7 mRNA as well as colposcopy and cervical biopsy. Results: In the 197 cases,positive HPV E6 / E7 mRNA was 62. 44%,and mRNA sensitivity was 91. 18%; specificity,52. 17%; positive predictive value,50. 14%; negative predictive value,91. 89%. By histological grading,the difference was significant regarding the positive rate of HPV E6 /E7 mRNA between inflammatory group and cervical intraepithelial neoplasia( CIN) Ⅰ,CIN Ⅱor CIN Ⅲ( P〈0. 01). The result of HPV E6 / E7 mRNA expression was consistent with that of pathological findings in 90% of the cases. Conclusion: HPV E6 / E7 mRNA expression is closely correlated with cervical lesions,and can be a useful tool to assess the risks of malignancy. Particularly,HPV E6 / E7 mRNA detection can competently predict high grade CIN from early or low grade cervical lesions.
作者 徐多 何莲芝
出处 《皖南医学院学报》 CAS 2016年第3期230-233,共4页 Journal of Wannan Medical College
关键词 人乳头瘤病毒 HPV E6/E7 mRNA 子宫颈上皮内瘤样病变 human papillomavirus HPV E6 /E7 mRNA cervical intraepithelial neoplasia
  • 相关文献

参考文献12

  • 1郎景和.子宫颈上皮内瘤变的诊断与治疗[J].中华妇产科杂志,2001,36(5):261-263. 被引量:1249
  • 2SCHIFFMAN M,WENTZENSEN N. Human papillomavirus infectionand the multistage carcinogenesis of cervical cancer[J] . CancerEpidemiol Biomarkers Prev,2013 ,2 2 :553 -5 6 0 .
  • 3GOLDBERG RM ,M ER0P0L NJ,TABERNERO ,e t a l Ac-complishmentsin 2008 in the treatment of advanced metastatic colorectalcancer[J] . Gastrointest Cancer R es, 2009,3 ( Suppl 2 ) : S23 -S27.
  • 4MASSIMI P,SHAI A,LAMBERT P ,e i al. HPV E6 degradat ion ofp53and PDZ containingsubstrat es in anE6AP null background[J] . Oncogene, 2008,27 (1 2 ) : 1800 -1 8 0 4 .
  • 5DARNELL GA, SCHRODER WA,ANTALIS T M ,ef al. Humanpapillomavirus E7 requires the protease calpain to degrade the retinoblastomaprotein [J]. J Biol Chem, 200 7 ,2 8 2 ( 5 2 ) : 37492 -34500.
  • 6KRAUS I,M 0LD EN T ,H 0LM R ,e t al. Presenee of E6 and E7mRNA from human papillomavirus types 1 6 ,1 8 ,3 1 ,3 3 and 45 in the majority of cervical carcinomas [J]. J Clin Microbiol,2006,4 4 :1 3 1 0 -1 3 3 1 .
  • 7DOORBAR J. Molecular biology of human papillomavirus infectionand cervical cancer [J] . Clin Sc ( Lond ) , 20 0 6 ,1 1 0 ( 5 ) : 525 -541.
  • 8CASTLE PE,SHABER R ,L A MERE al. Human papillomavirus( H P V ) genotypes in women with cervical precancer andcancer at Kaiser Permanente Northern California [J] . Cancer EpidemiolBiomarkers Prev,2011,2 0 (5 ) :946 -9 5 3 .
  • 9贾政军,周玉春,胡蓉,彭向京,黄定梅,王华,王丹,何思.HPV mRNA实时荧光定量PCR检测及其与宫颈癌发生的关系[J].实用预防医学,2012,19(3):354-358. 被引量:13
  • 10RATNAM S U T L E E F,FONTAINE B ,e t al. Clinical performanceof the PreTect HPV-Proofer E 6/E 7 mRNA assay in compgirisonwith that of the Hybrid Capture 2 test for identification ofwomen at risk of cervical cancer[J] . Journal of clinical microbiology,2 0 1 0 ,4 8 (8 ) :2779.

二级参考文献19

  • 1罗建湘,吕文玲,谢聪莉,冯雪萍.宫颈上皮内瘤病及宫颈癌与HPV感染关系的探讨[J].实用预防医学,2007,14(1):75-77. 被引量:10
  • 2何桂蓉,刘忠.高危型HPV型别、病毒载量与宫颈癌前病变的相关性研究[J].现代检验医学杂志,2007,22(4):32-35. 被引量:22
  • 3Vernon SD,Unger ER,Reeves WC.Human papillomavirus and cer-vival cancer[J].Curr Prob Obstet Gynecol Fertil,1998,2(4):104.
  • 4Zur Hausen H,Meinhof W,Scheiber W,et al.Attempts to detectvirus-specific DNA sequence in human tumors:nucleic acid hybridiza-tion with complementary RNA of human wart virus[J].In.
  • 5Muz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification ofhuman papillomavirus types associated with cervical cancer[J].N EnglJ Med,2003,348:518-527.
  • 6Czegledy J,Veress G,Konya J,et al.Genital human papillomavirus(HPV)infection in Hungarian women[J].Acta Microbiologica Hun-garica,1993,40(2):115-122.
  • 7Kruse AJ,Skaland I,Janssen EA,et al.Quantitative molecular param-eters to identify low-risk and high-risk early CIN lesions:role ofmarkers of proliferative activity and different.
  • 8Katase K,Teshima H,Hirai Y,et al.Natural history of cervical humanpapillomavirus lesions[J].Intervirology,1995,38(3-4):192-194.
  • 9Munger K,Yee CL,Phelps WC,et al.Biochemical and biological differ-ences between E7 oncoproteins of the high-and low-risk human pa-pillomavirus types are determined by amino-termi.
  • 10Chen LP,Thomas E K,Hu SL,et al.Human papillomavirus type16necleoprotein E7 is a tumor rejection antigen[J].Proc Natl Acad SciUSA,1991,88:110-114.

共引文献1260

同被引文献28

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部